Back to News

press-release January 23, 2025

Are MultiSite Research Orgs The Future

Proud member of AMRC.org badge graphic, blue

Javara was today announced as a founding member of the newly launched Association of MultiSite Research Corporations (AMRC)

This groundbreaking trade association brings together 14 leading multisite organizations to transform the clinical trial industry, driving operational efficiency, improving patient outcomes, and creating scalable solutions for modern research challenges.

At Javara, we lead the way as a pioneering Integrated Research Organization (IRO), bringing Clinical Research as a Care Option (CRAACO) directly to patients through trusted healthcare systems and physicians. Our embedded teams, centralized resources, and standardized operations eliminate barriers to participation and accelerate study timelines, enabling better representation and quality outcomes in clinical trials. Jennifer Byrne, Javara Founder and CEO and AMRC founding member, explains:

The current system is archaic in its view of the PI as solely responsible for everything. The multisite approach builds a moat around the PI, providing essential support while standardizing processes to create efficient forums for sharing best practices. It transforms a fragmented system into a scalable, pragmatic solution.

Javara is proud to join AMRC in reshaping clinical trials and transforming healthcare through the power of predictability. Together, we are building a future where clinical research is faster, safer, and more accessible. Learn more about AMRC and join us at the launch webinar at www.amrc.org/news.

Advocating for a multisite approach:

    • AMRC promotes the benefits of multisite clinical research corporations, highlighting their ability to streamline trial processes, improve data quality, and accelerate timelines.
    • The association works to create standardized practices across multisite organizations, fostering collaboration and ensuring consistency in clinical trial execution.
    • AMRC acts as a bridge between multisite networks, pharmaceutical companies, contract research organizations (CROs), and regulators, facilitating communication and ensuring the unique capabilities of these organizations are recognized and leveraged.

For additional informational resources, contact us today!

Share